Novo Nordisk A/S (NYSE:NVO) is the largest Danish pharmaceutical company focusing on developing medicines to combat obesity, diabetes, cardiovascular diseases and non-alcoholic steatohepatitis. Since ...
Source LinkNovo Nordisk A/S (NYSE:NVO) is the largest Danish pharmaceutical company focusing on developing medicines to combat obesity, diabetes, cardiovascular diseases and non-alcoholic steatohepatitis. Since ...
Source Link
Comments